Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage

Pharmacology Biochemistry and Behavior

Volumn 105, Issue , 2013, Pages 63-70

  Jindal, Ankur ^a   Mahesh, Radhakrishnan ^a   Bhatt, Shvetank ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Antidepressant; CUMS; Etazolate; Oxidative stress; Phosphodiesterase 4

Indexed keywords

ANTIOXIDANT; CATALASE; ETAZOLATE; FLUOXETINE; GLUTATHIONE; NITRITE; SUCROSE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; ENZYME ACTIVITY; IMMOBILIZATION; LIPID PEROXIDATION; LOCOMOTION; LONG TERM CARE; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR, ANIMAL; BRAIN; CHRONIC DISEASE; ETAZOLATE; FLUOXETINE; HUMANS; LIPID PEROXIDATION; MICE; OXIDATIVE STRESS; PHOSPHODIESTERASE INHIBITORS; STRESS, PSYCHOLOGICAL;

MUS; RODENTIA;

EID: 84876069092     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.01.020     Document Type: Article

References (72)

1. M. Aan het Rot, K.A. Collins, and H.L. Fitterling Physical exercise and depression Mt Sinai J Med 76 2009 204 214
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed. 1994 APA Press Washington DC [DSM-IV]
3. H. Anisman Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder J Psychiatry Neurosci 34 2009 4 20
4. M. Atmaca, E. Tezca, M. Kuloglu, B. Ustundag, and H. Tunckol Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment Eur Arch Psychiatry Clin Neurosci 254 2004 231 235 (Pubitemid 39312836)
5. B. Beer, M. Chasin, D.E. Clody, and J.R. Vogel Cyclic adenosine monophosphate phosphodiesterase in brain: effect on anxiety Science 176 1972 428 430
6. M. Berk Oxidative biology: new intervention opportunities in psychiatry Acta Neuropsychiatr 19 2007 259 260 (Pubitemid 47087573)
7. M. Bilici, H. Efe, M.A. Koroglu, H.A. Uydu, M. Bekaroglu, and O. Deger Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments J Affect Disord 64 2001 43 51 (Pubitemid 32268670)
8. J.R. Boissier, and P. Simon Action of caffeine on the spontaneous motility of the mouse Arch Int Pharmacodyn Ther 158 1965 212 221
9. C.O. Bondi, G. Rodriguez, G.G. Gould, A. Frazer, and D.A. Morilak Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment Neuropsychopharmacology 33 2008 320 331 (Pubitemid 350243351)
10. P.C. Casarotto, and R. Andreatini Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone Eur Neuropsychopharmacol 17 2007 735 742 (Pubitemid 47432838)
11. D.S. Charney, and H.K. Manji Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention Sci STKE 225 2004 1e11
12. E.R. De Kloet, M. Joels, and F. Holsboer Stress and the brain: from adaptation to disease Nat Rev Neurosci 6 2005 463 475 (Pubitemid 40769171)
13. M.J. Detke, J. Johnson, and I. Lucki Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression Exp Clin Psychopharmacol 5 1997 107 112 (Pubitemid 27239810)
14. J. Drott, L. Desire, D. Drouin, M. Pando, and F. Haun Etazolate improves performance in a foraging and homing task in aged rats Eur J Pharmacol 634 2010 95 100
15. C. Ducottet, G. Griebel, and C. Belzung Effects of the selective nonpeptide corticotrophin releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice Prog Neuropsychopharmacol Biol Psychiatry 27 2003 625 631 (Pubitemid 36645063)
16. G.L. Ellman Tissue sulfidryl groups Arch Biochem Biophys 82 1959 70 77
17. I. Eren, M. Naziroglu, A. Demirdas, O. Celik, A.C. Uguz, and A. Altunbasak Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat Neurochem Res 32 2007 497 505 (Pubitemid 46295149)
18. I. Eren, M. Naziroglu, and A. Demirdas Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain Neurochem Res 32 2007 1188 1195 (Pubitemid 46817468)
19. F.U. Fontella, I.R. Siqueira, A.P.S. Vasconcellos, A.S. Tabajara, C.A. Netto, and C. Dalmaz Repeated restraint stress induces oxidative damage in rat hippocampus Neurochem Res 30 2005 105 111 (Pubitemid 40254210)
20. L.S. Garcia, C.M. Comim, S.S. Valvassori, G.Z. Réus, L. Stertz, and F. Kapczinski Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats Prog Neuropsychopharmacol Biol Psychiatry 33 2009 450 455
21. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum Analysis of nitrate, nitrite, and [15 N]nitrate in biological fluids Anal Biochem 126 1982 131 138 (Pubitemid 13203451)
22. T.B. Halene, and S.J. Siegel PDE inhibitors in psychiatry - future options for dementia, depression and schizophrenia Drug Discov Today 12 2007 870 878 (Pubitemid 47539966)
23. B.L. Hankin Adolescent depression: description, causes, and interventions Epilepsy Behav 8 2006 102 114 (Pubitemid 43103838)
24. C. Heim, D.J. Newport, T. Mletzko, A.H. Miller, and C.B. Nemeroff The link between childhood trauma and depression: insights from HPA axis studies in humans Psychoneuroendocrinology 33 2008 693 710
25. F. Holsboer The corticosteroid receptor hypothesis of depression Neuropsychopharmacology 23 2000 477 501
26. Z.P. Horovitz, B. Beer, D.E. Clody, J.R. Vogel, and M. Chasin Cyclic AMP and anxiety Psychosomatics 13 1972 85 92
27. A. Jindal, R. Mahesh, B. Gautam, S. Bhatt, and D. Pandey Antidepressant-like effect of etazolate, a cyclic nucleotide phosphodiesterase 4 inhibitor - an approach using rodent behavioral antidepressant tests battery Eur J Pharmacol 689 2012 125 131
28. R.J. Katz, K.A. Roth, and B.J. Carroll Acute and chronic stress effects on open field activity in the rat: implications for a model of depression Neurosci Biobehav Rev 5 1981 247 251 (Pubitemid 11074538)
29. S.D. Khanzode, G.N. Dakhale, S.S. Khanzode, A. Saoji, and R. Palasodkar Oxidative damage and major depression: the potential antioxidant action of selective serotonin reuptake inhibitors Redox Rep 8 2003 365 370 (Pubitemid 38128544)
30. N. Kolla, Z. Wei, J.S. Richardson, and X.M. Li Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide J Psychiatry Neurosci 30 2005 196 201 (Pubitemid 40942458)
31. B. Kumar, A. Kuhad, and K. Chopra Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences Psychopharmacology (Berl) 214 2011 819 828
32. M.H. Larsen, J.D. Mikkelsen, A. Hay-Schmidt, and C. Sandi Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment J Psychiatr Res 44 2010 808 816
33. J. Lee, W. Duan, and M.P. Mattson Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice J Neurochem 82 2002 1367 1375
34. N. Li, R.J. Liu, J.M. Dwyer, M. Banasr, B. Lee, and H. Son Glutamate N-methyl-d-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure Biol Psychiatry 69 2011 754 761
35. X.Y. Lu, C.S. Kim, A. Frazer, and W. Zhang Leptin: a potential novel antidepressant Proc Natl Acad Sci U S A 103 2006 1593 1598 (Pubitemid 43191210)
36. G. Lucca, C.M. Comim, S.S. Valvassori, G.Z. Réus, F. Vuolo, and F. Petronilho Effects of chronic mild stress on the oxidative parameters in the rat brain Neurochem Int 54 2009 358 362
37. D.D. Luo, S.C. An, and X. Zhang Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress Brain Res Bull 77 2008 8 12
38. S.J. MacKenzie, and M.D. Houslay Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element- binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells Biochem J 347 2000 571 578 (Pubitemid 30229406)
39. J.L. Madrigal, R. Olivenza, M.A. Moro, I. Lizasoain, P. Lorenzo, and J. Rodrigo Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain Neuropsychopharmacology 24 2001 420 429 (Pubitemid 32157558)
40. M. Maes, N. De Vos, R. Pioli, P. Demedts, A. Wauters, and H. Neels Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness J Affect Disord 58 2000 241 246 (Pubitemid 30232781)
41. M. Maes, R. Yirmyia, J. Noraberg, S. Brene, J. Hibbeln, and G. Perini The inflammatory and neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression Metab Brain Dis 24 2009 27 53
42. R. Mahesh, R. Rajkumar, B. Minasri, and R. Venkatesha Perumal Potential antidepressants: pharmacology of 2-(4-methylpiperazin-1-yl)-1,8-naphthyridine- 3carbonitrile in rodent behavioral models Pharmazie 62 2007 919 924 (Pubitemid 350305768)
43. H.K. Manji, and R.S. Duman Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics Psychopharmacol Bull 35 2001 5 49
44. Q.Q. Mao, S.P. Ip, K.M. Ko, S.H. Tsai, and C.T. Che Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor Prog Neuropsychopharmacol Biol Psychiatry 33 2009 1211 1216
45. B.S. McEwen Glucocorticoids, depression, and mood disorders: structural remodeling in the brain Metabolism 54 2005 20 23 (Pubitemid 40546018)
46. M.T. McKenna, C.M. Michaud, C.J.L. Murray, and J.S. Marks Assessing the burden of disease in the United States using disability-adjusted life years Am J Prev Med 28 2005 415 423 (Pubitemid 40719042)
47. T.M. Michel, S. Frangou, D. Thiemeyer, S. Camara, J. Jecel, and K. Nara Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder - a postmortem study Psychiatry Res 151 2007 145 150 (Pubitemid 46634625)
48. H.P. Misra, and I. Fridovich The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase J Biol Chem 247 1972 3170 3175
49. M. Moretti, A. Colla, G. de Oliveira Balen, D.B. dos Santos, J. Budni, and A.E. de Freitas Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress J Psychiatr Res 46 2012 331 340
50. N. Naitoh, S. Nomura, Y. Kunimi, and K. Yamaoka Swimming-induced "head twitching" in rats in the forced swimming test induced by overcrowding stress: a new marker in the animal model of depression? Keio J Med 41 1992 221 224
51. C.B. Nemeroff The burden of severe depression: a review of diagnostic challenges and treatment alternatives J Psychiatr Res 41 2007 189 206 (Pubitemid 44854991)
52. F. Ng, M. Berk, O. Dean, and A.I. Bush Oxidative stress in psychiatric disorders: evidence base and therapeutic implications Int J Neuropsychopharmacol 11 2008 851 876
53. J. Nirmal, C.S. Babu, T. Harisudhan, and M. Ramanathan Evaluation of behavioural and antioxidant activity of Cytisus scoparius Link in rats exposed to chronic unpredictable mild stress BMC Complement Altern Med 8 2008 15
54. S.N. Pal, and P.C. Dandiya Glutathione as a cerebral substrate in depressive behavior Pharmacol Biochem Behav 48 1994 845 851 (Pubitemid 24259812)
55. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch Int Pharmacodyn Ther 229 1977 327 336 (Pubitemid 8225714)
56. S.M. Rothman, and M.P. Mattson Adverse stress, hippocampal networks, and Alzheimer's disease Neuromolecular Med 12 2010 56 70
57. A. Sarandol, E. Sarandol, S.S. Eker, S. Erdinc, E. Vatansever, and S. Kirli Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems Hum Psychopharmacol 22 2007 67 73 (Pubitemid 46505714)
58. V. Sharma, A. Bala, R. Deshmukh, K.L. Bedi, and P.L. Sharma Neuroprotective effect of RO-20-1724 - a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats Pharmacol Biochem Behav 101 2012 239 245
59. R.C. Shelton, D.H. Mainer, and F. Sulser cAMP-dependent protein kinase activity in major depression Am J Psychiatry 153 1996 1037 1042 (Pubitemid 26264704)
60. J.S. Silvestre, A.G. Fernandez, and J.M. Palacios Preliminary evidence for an involvement of the cholinergic system in the sedative effects of rolipram in rats Pharmacol Biochem Behav 64 1999 1 5 (Pubitemid 29415789)
61. A.K. Sinha Colorimetric assay of catalase Anal Biochem 47 1972 389 394
62. E. Suzuki, G. Yagi, T. Nakaki, S. Kanba, and M. Asai Elevated plasma nitrate levels in depressive states J Affect Disord 63 2001 221 224 (Pubitemid 32200517)
63. H. Takeda, M. Tsuji, T. Yamada, J. Masuya, K. Matsushita, and M. Tahara Caffeic acid attenuates the decrease in cortical BDNF mRNA expression induced by exposure to forced swimming stress in mice Eur J Pharmacol 534 2006 115 1121
64. H. Tsuboi, A. Tatsumi, K. Yamamoto, F. Kobayashi, K. Shimoi, and N. Kinae Possible connections among job stres, depressive symptoms, lipid modulation and antioxidants J Affect Disord 91 2006 63 70 (Pubitemid 43254640)
65. P. Wang, J.G. Myers, P. Wu, B. Cheewatrakoolpong, R.W. Egan, and M.M. Billah Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D Biochem Biophys Res Commun 234 1997 320 324 (Pubitemid 27243900)
66. P. Willner Validity, reliability and utility of the chronic mild stress model of depression, a 10-year review and evaluation Psychopharmacology (Berl) 134 1997 319 329 (Pubitemid 28023396)
67. P. Willner Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS Neuropsychobiology 52 2005 90 110 (Pubitemid 41160326)
68. E.D. Wills Mechanism of lipid peroxide formation in animal Biochem J 99 1966 667 676
69. A. Zafir, A. Ara, and N. Banu In vivo antioxidant status: a putative target for antidepressant action Prog Neuropsychopharmacol Biol Psychiatry 33 2009 220 228
70. D. Zhang, X.S. Wen, X.Y. Wang, M. Shi, and Y. Zhao Antidepressant effect of Shudihuang on mice exposed to unpredictable chronic mild stress J Ethnopharmacol 123 2009 55 60
71. C. Zhao, W. Deng, and F.H. Gage Mechanisms and functional implications of adult neurogenesis Cell 132 2008 645 660 (Pubitemid 351253687)
72. Q.G. Zhou, Y. Hu, Y. Hua, M. Hu, C.X. Luo, and X. Han Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis J Neurochem 103 2007 1843 1854 (Pubitemid 350126635)